Brothers in armsMarch 17, 2009Researchers from Helmholtz-Centre in Braunschweig and immunologists from Magdeburg investigate the connection of flu and pneumonia A joint venture from researchers from the Helmholtz-Centre for Infection Research (HZI) in Braunschweig, the Otto-von-Guericke-University in Magdeburg, and the Karolinska institute in Sweden have taken an in-depth look at the connection between flu infection and pneumonia. Their results, recently released in the scientific journal "PLoS One", have disproven a common theory about flu-like pneumonia. Some viral infections trigger a decrease of immune cells in the blood - a so-called "lymphopenia". The reasons behind it and whether this is the case with influenza are unknown. To investigate the latter, HZI researchers infected mice with flu viruses and measured the amount of immune cells in the animal's blood every day. Some days later, flu-infected mice received a dosage of pneumonia bacteria usually harmless for healthy mice. While the flu-infected mice did develop a superinfection & subsequently died, surprisingly, they were not suffering from lymphopenia. The healthy, non-flu-infected mice defeated the bacteria successfully and recovered. To discover whether a lack of immune cells encourages an infection with pneumonia bacteria in general, an artificial drug-induced lymphopenia was established in the mice. Without infecting these lymphopenic mice with flu viruses, they received pneumonia bacteria. Despite a severe lack of immune cells, the mice recovered completely. With these results, the researchers could show that influenza facilitates and intensifies an infection from pneumonia bacteria, while disproving the common idea that this is caused by a lack of immune cells. "This result was an enormous surprise for us because it directly contradicts widespread assumptions", says Sabine Stegemann, researcher in the groups "Immune regulation" at the HZI and "Molecular Immunology" at the Otto-von-Guericke-University in Magdeburg. "Now we want to understand the reasons for the increased susceptibility", says Matthias Gunzer, head of the group in Magdeburg. "It could be interplay of weakened mucous membranes and scavenger cells that induce ideal conditions for pneumonia bacteria to create a deadly lung infection. Another reason may be a reaction of the host immune system: It disables hyperactive flu-fighting immune cells to inhibit destruction of healthy lung tissue. "The immune system keeps itself under control and that makes it easy for pneumonia bacteria to infect the lung", says Gunzer. Helmholtz Association of German Research Centres |
|||||||||||||||||||||
| Related Pneumonia Current Events and Pneumonia News Articles Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. Fewer emergency patients seen within recommended time frame One in four emergency department patients in 2006 waited longer to be evaluated by a clinician than recommended at triage, an increase from one in five in 1997. Possible help in fight against muscle-wasting disease A compound already used to treat pneumonia could become a new therapy for an inherited muscular wasting disease, according to researchers at the University of Oregon and the University of Rochester School of Medicine and Dentistry in New York. Henry Ford Hospital study: A MRSA strain linked to high death rates A strain of MRSA that causes bloodstream infections is five times more lethal than other strains and has shown to have some resistance to the potent antibiotic drug vancomycin used to treat MRSA, according to a Henry Ford Hospital study. Commentary warns of unexpected consequences of proton pump inhibitor use in reflux disease Despite being highly effective and beneficial for many patients, unexpected consequences are emerging in patients who are prescribed proton pump inhibitors (PPIs) for reflux diseases. Scientists discover influenza's Achilles heel: Antioxidants As the nation copes with a shortage of vaccines for H1N1 influenza, a team of Alabama researchers have raised hopes that they have found an Achilles' heel for all strains of the flu-antioxidants. Lessons from flu seasons past Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons. Older Patients with Dementia at Increased Risk for Flu Mortality An epidemiological study on pneumonia and influenza (P&I) in adults age 65 and over reports that patients with dementia are diagnosed with flu less frequently, have shorter hospital stays, and have a fifty percent higher rate of death than those without dementia. OMRF scientists discover promising new path for treating traumas A discovery by scientists at the Oklahoma Medical Research Foundation could help save lives threatened by traumatic injuries like those sustained in car crashes or on the battlefield. The work also holds potential for treating severe infectious diseases and diabetes. Scientists create NICE solution to pneumonia vaccine testing problems Medical clinics the world over could benefit from new software* created at the National Institute of Standards and Technology (NIST), where a team of scientists has found a way to improve the efficiency of a pneumonia vaccine testing method developed at the University of Alabama at Birmingham (UAB). More Pneumonia Current Events and Pneumonia News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||